Febarbamate: metabolism in man

Area of Science:

• Pharmacology and Toxicology
• Drug Metabolism Studies
• Organic Chemistry

Background:

• Febarbamate is a pyrimidine derivative with potential therapeutic applications.
• Understanding the metabolic fate of drugs is crucial for assessing efficacy and safety.
• Human biotransformation studies provide essential data for pharmacokinetic and pharmacodynamic modeling.

Purpose of the Study:

• To elucidate the metabolic pathways of febarbamate in humans.
• To identify and characterize the major urinary metabolites of febarbamate.
• To investigate the structural modifications of febarbamate in vivo.

Main Methods:

• Oral administration of febarbamate (15 mg/kg) to human volunteers.
• Urine sample collection and analysis.
• Separation and purification of metabolites using Amberlite XAD-2 extraction and High-Performance Liquid Chromatography (HPLC).
• Structural elucidation of metabolites via Mass Spectrometry (MS) and Nuclear Magnetic Resonance (NMR) spectroscopy, and comparison with known standards.

Main Results:

• Twenty-two urinary metabolites of febarbamate were identified.
• Four major metabolites were characterized, resulting from oxygen dealkylation, n-butyl chain hydroxylation with subsequent oxidation to a ketone, and C4 hydroxylation of the benzene ring.
• Specific major metabolites identified include 1-(2-carbamoyloxy-3-hydroxypropyl)-5-ethyl-5-phenyl-(1H,3H,5H)-pyrimidine-2,4,6-trione (41.4%), 1-[3-(3-hydroxybutoxy)-2-carbamoyloxypropyl]-5-ethyl-5-phenyl-(1H,3H,5H)-pyrimidine-2,4,6-trione (20.2%), 1-[3-(3-oxobutoxy)-2-carbamoyloxypropyl]-5-ethyl-5-phenyl-(1H,3H,5H)-pyrimidine-2,4,6-trione (11.1%), and 1-(2-carbamoyloxy-3-hydroxypropyl)-5-ethyl-5-(4-hydroxyphenyl)-(1H,3H,5H)-pyrimidine-2,4,6-trione (9.2%).
• Insignificant hydrolysis of the carbamoyloxy group, no pyrimidine ring opening, and no oxidation of the 5-ethyl group were observed.
• Only trace amounts of the parent febarbamate drug were detected in urine.

Conclusions:

• Febarbamate undergoes extensive biotransformation in humans, primarily through oxidative pathways.
• The identified metabolites provide insight into the drug's metabolic profile and potential routes of excretion.
• The study establishes the main metabolic fate of febarbamate, with minimal degradation of the core structure observed.